The global market for assisted reproductive technologies (ART) such as IVF and ICSI is predicted to grow substantially, reaching $53.8 billion by the end of 2030. This growth is driven by increasing infertility rates, technological advances in ART, and rising acceptance of fertility treatments. The UK market is also seeing expansion with startups like London-based Hertility Health, which focuses on women’s reproductive health, gaining traction. The report also highlights that the IVF segment dominates the ART market and is expected to continue its dominance through 2030.